Treatment and/or prevention of parkinson's disease dementia with ceftriaxone
View Patent ↗Disclosed herein is a method for treatment of a human subject having or suspected of having Parkinson's disease dementia, which includes administering to the human subject ceftriaxone at a daily dosage ranging from about 1.5 mg to about 35 mg per kilogram of a body weight of the human subject.
1. A method for treating Parkinson's disease dementia in a human subject, comprising administering to the human subject ceftriaxone at a daily dosage ranging from about 1.5 mg to about 35 mg per kilogram of a body weight of the human subject.
2. The method as claimed in claim 1 , wherein ceftriaxone is administered to the human subject at a daily dosage ranging from about 1.62 mg to about 32.4 mg per kilogram of the body weight of the human subject.
3. The method as claimed in claim 2 , wherein ceftriaxone is administered to the human subject at a daily dosage ranging from about 1.62 mg to about 16.2 mg per kilogram of the body weight of the human subject.
4. The method as claimed in claim 3 , wherein ceftriaxone is administered to the human subject at a daily dosage ranging from about 1.62 mg to about 8.1 mg per kilogram of the body weight of the human subject.
5. The method as claimed in claim 1 , wherein ceftriaxone is parenterally administered to the human subject.
6. The method as claimed in claim 1 , wherein ceftriaxone is orally administered to the human subject.
7. A method for treating Parkinson's disease dementia in a human subject, comprising administering to the human subject ceftriaxone at a daily dosage ranging from about 1.5 mg to about 35 mg per kilogram of a body weight of the human subject to ameliorate cognitive functions of the human subject.